Abstract:Abstract Background Despite the diagnosis and treatment of tuberculosis (TB) given free of charge in many high-burden countries, the costs that patients face in the cascade of care remain a major concern. Here, we aimed to investigate the financial burden of TB diagnosis and treatment for people with TB in Ethiopia. Method For this systematic review and meta-analysis, we searched PubMed/MEDLINE, Embase, and Cochrane Center for Clinical Trials from December 1 2022 to 31 June 2023 for articles reporting the cost of diagnosis and treatment for patients regardless of their age with all forms of TB in Ethiopia. Major study outcomes were catastrophic costs, direct (out-of-pocket) pre-diagnosis, medical cost, and post-diagnosis costs, indirect (income loss) costs, coping costs, and total costs. We have used a threshold of 20% to define catastrophic costs. We used random-effects meta-analyses to calculate summary estimates of costs. R-studio software was used for analysis. The study is registered with PROSPERO: CRD42023387687. Result Twelve studies, with a total of 4792 patients with TB, were included in our analysis. At the 20% threshold of total expenses, 51% of patients (2301 participants from 5 studies, 95% CI: 36-65%, I 2 = 97%) faced catastrophic costs due to bacteriologically confirmed drug-sensitive pulmonary TB. Private facility diagnosis, drug-resistance TB, TB-HIV co-infection, hospitalization, and occupation were found to be associated with catastrophic costs. Reduction in the total cost spent by the patients was associated with digital adherence interventions, community-based direct observed therapy, short-course MDR-TB treatment regimens, and active case-finding. Pre-diagnosis costs had a positive correlation with diagnosis delays and the number of facilities visited until diagnosis. Post-diagnosis costs had a positive correlation with rural residence and inpatient treatments. Conclusion Irrespective of a national policy of free TB service, more than half of TB patients are suffering catastrophic costs due to drug-sensitive pulmonary TB in Ethiopia and most of the patients spend a lot of money during the pre-diagnosis period and intensive phase, but declined drastically over time. Active case-finding, digital adherence interventions, community-based treatment, and comprehensive health insurance coverage have the potential to minimize the financial burden of TB diagnosis and treatment.

Patient costs for drug-resistant TB diagnosis and pre-treatment evaluation in North India

Catastrophic costs for tuberculosis patients in India: Impact of methodological choices

Cohort study on association between catastrophic costs and unfavorable tuberculosis treatment outcomes among TB-HIV and TB-diabetes comorbid patients in India

Financial burden of tuberculosis diagnosis and treatment for patients in Ethiopia: a systematic review and meta-analysis

Journey of the tuberculosis patients in India from onset of symptom till one-year post-treatment

Averting catastrophic tuberculosis costs in an Indian state: integration of Ayushman Bharat Arogya Karnataka with National Tuberculosis Elimination Program

Estimation of potential social support requirement for tuberculosis patients in India

A sequential explanatory mixed-methods study on costs incurred by patients with tuberculosis comorbid with diabetes in Bhavnagar, western India

Pre-treatment delay and out of pocket expenses by notified new tuberculosis patients in an Indian mega city

TB-related catastrophic costs in Ethiopia

Costs of non-multidrug-resistant pulmonary tuberculosis and of preventive treatment in Germany - An update

Quantitative Study of Physical, Social, Psychological, and Environmental Challenges Faced by Patients With Drug-Resistant Tuberculosis

Non-medical financial burden in tuberculosis care: a cross-sectional survey in rural China

Assessment of treatment outcomes of daily fixed-dose combination therapy among drug-sensitive pulmonary tuberculosis patients: A prospective study from Bengaluru, India

Economic implications of novel regimens for tuberculosis treatment in three high-burden countries: a modelling analysis

Estimating Catastrophic Costs due to Pulmonary Tuberculosis in Bangladesh

Catastrophic costs incurred by tuberculosis affected households from Thailand's first national tuberculosis patient cost survey

Catastrophic costs of tuberculosis care in a population with internal migrants in China

[Study on the direct economic burden and relevant influencing factors of 233 multidrug/rifampicin-resistant pulmonary tuberculosis patients in Jiangsu Province]

DISPARITIES IN "CATASTROPHIC" OUT-OF-POCKET COST INCURRED FROM MULTI-DRUG RESISTANT TUBERCULOSIS TREATMENT AMONG MIGRANT AND RESIDENT PATIENTS IN GUANGZHOU, GUANGDONG PROVINCE, PR CHINA

Tuberculosis patients face high treatment support costs in Colombia, 2021